ABIGAIL CONNELL: Open Payments
NPI 1801441530 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,572 in 90 payments from 17 companies in 2025. Trend: 2023 $2,271 · 2024 $2,719 · 2025 $2,572
Food & beverage: $2,562Education: $10
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $386 |
| ABBVIE INC. | 14 | $371 |
| Amgen Inc. | 17 | $281 |
| Corcept Therapeutics | 4 | $271 |
| Lilly USA, LLC | 8 | $254 |
| Novo Nordisk Inc | 6 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $177 |
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| Astellas Pharma US Inc | 5 | $160 |
| Actelion Pharmaceuticals US, Inc. | 2 | $140 |
Products named: VRAYLAR, Korlym, Kerendia, Veozah, KRYSTEXXA, NURTEC ODT, Ozempic, MOUNJARO.
Industry payments across NV — which companies pay providers there.
